Jing Yang

Jing Yang currently serves as the Vice President and Head of Clinical Pharmacology/DMPK at Neomorph, Inc., a position held since May 2025. Prior roles include Executive Director, Head of Clinical Pharmacology/DMPK at Boundless Bio and Director of Clinical Development in Clinical Pharmacology for Oncology at Pfizer. Jing Yang's career also encompasses significant positions at Alpine Immune Sciences, Seattle Genetics, AbbVie, and academic research at the University of Washington. Educational qualifications include a PhD in Pharmaceutics from the University of Washington, an MS in Pharmacology from Oregon State University, and a background from China Pharmaceutical University.